Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 74, n° 6
pages 1241-1246 (juin 2016)
Doi : 10.1016/j.jaad.2016.01.008
accepted : 6 January 2016
Reviews

The role of biofilms in onychomycosis
 

Aditya K. Gupta, MD, PhD, FRCP(C) a, b, , Deanne Daigle, MSc b, Jessie L. Carviel, PhD b
a Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada 
b Mediprobe Research Inc, London, Ontario, Canada 

Reprint requests: Aditya K. Gupta, MD, PhD, FRCP(C), Mediprobe Research Inc, 645 Windermere Rd, London, Ontario, Canada N5X 2P1.Mediprobe Research Inc645 Windermere RdLondonOntarioN5X 2P1Canada
Abstract

Onychomycosis is a fungal infection of nails primarily caused by dermatophyte fungi. Fungi are traditionally understood as existing in the environment as planktonic organisms; however, recent advancements in microbiology suggest that fungi form biofilms–complex sessile microbial communities irreversibly attached to epithelial surfaces by means of an extracellular matrix. The extracellular matrix also acts as a protective barrier to the organisms within the biofilm. The biofilm is surprisingly resistant to injury and may act as a persistent source of infection possibly accounting for antifungal resistance in onychomycosis.

The full text of this article is available in PDF format.

Key words : antifungal, biofilm, dermatophyte fungi, extracellular matrix, nail, onychomycosis



 Funding sources: None.
 Disclosure: Dr Gupta has been a consultant for Anacor, Sandoz, and Moberg Pharma; been a clinical trials investigator for Valeant Canada, Nuvolase, Bristol Meyers Squibb, Eli Lilly, Merck, Novartis, Janssen, and Allergan; and served as a speaker for Valeant Canada, Janssen, Novartis, and Bayer. Ms Daigle and Dr Carviel are previous and present employees of Mediprobe Research Inc, which conducted the above trials.



© 2016  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline